Masaki Saito

Dr. Masaki Saito

Tohoku University Graduate School of Medicine
orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2017 in EMBO Reports
Verified
Journal Article
Open access
PDF file
MSMasaki Saito
Masaki Saito
WOWataru Otsu
Wataru Otsu
KHKuo-Shun Hsu
Kuo-Shun Hsu
JCJen‐Zen Chuang
Jen‐Zen Chuang
TYTeruyuki Yanagisawa
Teruyuki Yanagisawa
CSChing‐Hwa Sung
Ching‐Hwa Sung
The primary cilium is a plasma membrane‐protruding sensory organelle that undergoes regulated assembly and resorption. While the assembly process has been studied extensively, the cellular machinery that governs ciliary resorption is less well understood. Previous studies showed that the ciliary pocket membrane is an actin‐rich, endocytosis‐active periciliary subdomain. Furthermore, Tctex‐1, originally identified as a cytoplasmic dynein light chain, has a dynein‐independent role in ciliary resorption upon phosphorylation at Thr94. Here, we show that the remodeling and endocytosis of the ciliary pocket membrane are accelerated during ciliary resorption. This process depends on phospho(T94)Tctex‐1, actin, and dynamin. Mechanistically, Tctex‐1 physically and functionally interacts with the actin dynamics regulators annexin A2, Arp2/3 complex, and Cdc42. Phospho(T94)Tctex‐1 is required for Cdc42 activation before the onset of ciliary resorption. Moreover, inhibiting clathrin‐dependent endocytosis or suppressing Rab5GTPase on early endosomes effectively abrogates ciliary resorption. Taken together with the epistasis functional assays, our results support a model in which phospho(T94)Tctex‐1‐regulated actin polymerization and periciliary endocytosis play an active role in orchestrating the initial phase of ciliary resorption. Synopsis Ciliary resorption is causally linked to the G1‐S transition during the cell cycle. This study shows that Tctex‐1 phosphorylated at Thr94 triggers actin polymerization and periciliary endocytosis required for the initial phase of ciliary resorption. Ciliary pocket membrane endocytosis is increased during ciliary resorption. The actin regulators Cdc42, Arp2/3 and annexin 2 are downstream effectors of phospho(T94)Tctex‐1 in ciliary resorption. Tctex‐1‐regulated clathrin‐mediated endocytosis is actively involved in ciliary resorption.

22 December 2022 in Free Radical Biology and Medicine
Verified
Journal Article
Open access
NTNoriko Toda
Noriko Toda
TSTakeya Sato
Takeya Sato
MMMikio Muraoka
Mikio Muraoka
DLDelan Lin
Delan Lin
MSMasaki Saito
Masaki Saito
MYMASANORI YAMAUCHI
MASANORI YAMAUCHI
Doxorubicin (Dox), an anthracycline antibiotic, is an anticancer drug that inhibits DNA replication and cellular metabolic processes in cancer cells with high proliferative potential. However, Dox causes severe side effects, including myocardial damage and heart failure, but the molecular mechanism underlying Dox-induced myocardial injury remains uncertain. In the present study, we evaluated the effects of Dox on the mitochondrial quality control system and regulation of mitochondrial respiration and autophagy in an in vitro rat myoblast H9c2 cell culture model using western blotting, immunohistochemistry, the Seahorse XF24 system, and flow cytometry. Our results showed that Dox did not impair the initiation of autophagic flux or the functions of lysosomes; however, Dox affected the mitochondrial quality control system, leading to a fission-dominant morphology and impaired regulation of mitochondrial respiration, thereby increasing oxidative stress and inhibited progression of autophagy, particularly the fusion of autophagosomes with lysosomes. This inhibition caused a significant decrease in the formation of autolysosomes and was responsible for the accumulation of dysfunctional mitochondria and subsequent increase in oxidative stress, eventually leading to increased myocardial cell death.

1 January 1995 in The Journal of Biochemistry
Verified
Journal Article
Closed access
PDF file
YTYasuhito Terui
Yasuhito Terui
Yusuke FurukawaYusuke Furukawa
Yusuke Furukawa
KSKumi Sakoe
Kumi Sakoe
MOMasatsugu Ohta
Masatsugu Ohta
MSMasaki Saito
Masaki Saito
When human promyelocytic leukemia cell line HL-60 was treated with various differentiation-inducers, apoptosis always occurred after the full appearance of differentiation-related phenotypes. However, the two phenomena could be dissociated when HL-60 cells were treated with PDBu. When HL-60 cells were cultured with PDBu for more than 36 h, apoptosis was induced following differentiation. Apoptosis was not, however, observed when PDBu was removed within 24 h, even though induction of differentiation-related phenotypes, such as NBT-reducing ability and surface marker expression, was the same as that in the control. Northern blot analysis revealed that bcl-2 mRNA was rapidly down-regulated within 6 h of the treatment with PDBu. The amount of bcl-2 mRNA recovered to that of undifferentiated HL-60 cells when PDBu was washed out within 24 h. In contrast, the recovery of bcl-2 was incomplete when the cells were treated with PDBu for more than 36 h, suggesting that bcl-2 is also a critical regulator of the cell fate during myeloid differentiation. This hypothesis was confirmed by experiments using antisense oligonucleotides, i.e., blocking the recovery of bcl-2 mRNA by antisense oligonucleotides could result in the induction of apoptosis in HL-60 cells from which PDBu was removed within 24 h. Moreover, overexpression of BCL-2 in HL-60 cells could block apoptosis during differentiation without any significant effect on differentiation itself. These results strongly suggest that apoptosis is not a simple consequence of differentiation-induction, and that apoptosis and differentiation are regulated independently in myeloid cells.

15 July 2022 in Oncology Reports
Verified
Journal Article
Open access
PDF file
HSHiroyuki Suzuki
Hiroyuki Suzuki
TOTomokazu Ohishi
Tomokazu Ohishi
TATEIZO ASANO
TEIZO ASANO
TTTomohiro Tanaka
Tomohiro Tanaka
MSMasaki Saito
Masaki Saito
Yukinari KatoYukinari Kato
Yukinari Kato
Human epidermal growth factor receptor 2 (HER2) overexpression has been reported in various types of cancer, including breast, gastric, lung, colorectal and pancreatic cancer. A humanized anti‑HER2 monoclonal antibody (mAb), trastuzumab, has been shown to improve survival of patients in HER2‑positive breast and gastric cancer. An anti‑HER2 mAb, H2Mab‑77 (mouse IgG1, kappa) was previously developed. In the present study, a defucosylated version of mouse‑dog chimeric anti‑HER2 mAb (H77Bf) was generated. H77Bf possesses a high binding‑affinity [a dissociation constant (KD): 7.5x10‑10 M, as determined by flow cytometric analysis] for dog HER2‑overexpressed CHO‑K1 (CHO/dHER2) cells. H77Bf highly exerted antibody‑dependent cellular cytotoxicity (ADCC) and complement‑dependent cytotoxicity (CDC) for CHO/dHER2 cells by canine mononuclear cells and complement, respectively. Moreover, administration of H77Bf significantly suppressed the development of CHO/dHER2 xenograft tumor in mice compared with the control dog IgG. H77Bf also possesses a high binding‑affinity (KD: 7.2x10‑10 M) for a canine mammary gland tumor cell line (SNP), and showed high ADCC and CDC activities for SNP cells. Intraperitoneal administration of H77Bf in mouse xenograft models of SNP significantly suppressed the development of SNP xenograft tumors compared with the control dog IgG. These results indicated that H77Bf exerts antitumor activities against dHER2‑positive canine cancers, and could be valuable treatment regimen for canine cancers.

20 December 2021 in Cells
Verified
Journal Article
Open access
PDF file
GLGuanjie Li
Guanjie Li
TOTomokazu Ohishi
Tomokazu Ohishi
MKMika K. Kaneko
Mika K. Kaneko
JTJunko Takei
Junko Takei
TMTakuya Mizuno
Takuya Mizuno
Yukinari KatoYukinari Kato
Yukinari Kato
The epidermal growth factor receptor (EGFR) contributes to tumor malignancy via gene amplification and protein overexpression. Previously, we developed an anti-human EGFR (hEGFR) monoclonal antibody, namely EMab-134, which detects hEGFR and dog EGFR (dEGFR) with high sensitivity and specificity. In this study, we produced a defucosylated mouse–dog chimeric anti-EGFR monoclonal antibody, namely E134Bf. In vitro analysis revealed that E134Bf highly exerted antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity against a canine osteosarcoma cell line (D-17) and a canine fibroblastic cell line (A-72), both of which express endogenous dEGFR. Moreover, in vivo administration of E134Bf significantly suppressed the development of D-17 and A-72 compared with the control dog IgG in mouse xenografts. These results indicate that E134Bf exerts antitumor effects against dEGFR-expressing canine cancers and could be valuable as part of an antibody treatment regimen for dogs.

1 June 2000 in Microbiology and Immunology
Verified
Journal Article
Open access
PDF file
TTTorahiko Tanaka
Torahiko Tanaka
KSKazuo Sugiyama
Kazuo Sugiyama
MIMasanori Ikeda
Masanori Ikeda
ANAtsushi Naganuma
Atsushi Naganuma
ANAkito Nozaki
Akito Nozaki
NKNobuyuki Kato
Nobuyuki Kato
Hepatitis C virus (HCV) non‐structural protein 5B (NS5B) is an RNA replicase. We expressed full‐length NS5B (591 amino acid residues) in Escherichia coli as a fusion protein with maltose binding protein (MBP‐NS5B). MBP‐NS5B was recovered in the soluble fraction after centrifugation at 40,000 × g and affinity‐purified with amylose resin. The purified MBP‐NS5B had a high‐level of poly (A), oligo (U)‐dependent UMP incorporation with a Km of 2 μm for UTP. Surprisingly, the enzymatically active MBP‐NS5B was sedimented by ultracentrifugation at 160,000 × g. The pellet contained 16S and 23S ribosomal RNAs, suggesting that ribosomes were associated with MBP‐NS5B. Ribosomes and MBP‐NS5B were subsequently co‐purified on amylose resin. Deletion study revealed that either the N‐terminal (amino acid residues 1 107) or the C‐terminal (amino acid residues 498–591) region of NS5B were sufficient for this association with ribosomes. We further found that NS5B also bound with human ribosomes. Our results implicate a novel mechanism of coupling between replication and translation of the viral genome in the life cycle of HCV.